Study Stopped
The study was withdrawn prior to initiation. No participants were enrolled.
Mindfulness Training Versus Low (FODMAP) Fermentable Oligosaccharides, Disaccharides, Monosaccharides and Polyols Diet
FODMAP
Trial of Mindfulness-based Irritable Bowel Syndrome Eating Awareness Training as Compared to the Standard Low Fermentable Oligosaccharide, Disaccharide, Monosaccharide and Polyol Diet in Patients With Irritable Bowel Syndrome (IBS)
2 other identifiers
interventional
N/A
1 country
1
Brief Summary
The study aims to compare the effect of mindfulness-based awareness training in Irritable Bowel Syndrome (IBS) (MB-IBS-EAT) with the dietary standard of care (low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet) on patient's IBS symptoms
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started May 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 15, 2022
CompletedFirst Posted
Study publicly available on registry
November 30, 2022
CompletedStudy Start
First participant enrolled
May 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2026
April 23, 2026
August 1, 2025
2 months
November 15, 2022
April 20, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Global Improvement Scale (GIS) Scores Baseline
The Global Improvement Scale is an overall assessment of Irritable Bowel Syndrome (IBS) symptoms using a patient-defined 7-point Likert scale ranging from "substantially worse" to "substantially improved"
Baseline
Global Improvement Scale (GIS) Scores Week 1
The Global Improvement Scale is an overall assessment of Irritable Bowel Syndrome (IBS) symptoms using a patient-defined 7-point Likert scale ranging from "substantially worse" to "substantially improved"
Week 1
Global Improvement Scale (GIS) Scores Week 4
The Global Improvement Scale is an overall assessment of Irritable Bowel Syndrome (IBS) symptoms using a patient-defined 7-point Likert scale ranging from "substantially worse" to "substantially improved"
Week 4
Global Improvement Scale (GIS) Scores Week 8
The Global Improvement Scale is an overall assessment of Irritable Bowel Syndrome (IBS) symptoms using a patient-defined 7-point Likert scale ranging from "substantially worse" to "substantially improved"
Week 8
Global Improvement Scale (GIS) Scores Week 12
The Global Improvement Scale is an overall assessment of Irritable Bowel Syndrome (IBS) symptoms using a patient-defined 7-point Likert scale ranging from "substantially worse" to "substantially improved"
Week 12
Secondary Outcomes (11)
Change in Perceived Stress Level (PSS) Scores
Baseline, Week 1, Week 4, Week 8, and Week 12
Change in Five Factor Mindfulness Questionnaire (5FMQ) Scores
Baseline, Week 4, Week 8, and Week 12
Change in Mindful Eating Questionnaire (MEQ) Scores
Baseline, Week 8, and week 12
Change in Positive and Negative Affect Schedule (PANAS_State) Questionnaire Scores
Baseline, Week 8, and Week 12
Change in cortisol blood levels
Baseline and Week 8
- +6 more secondary outcomes
Study Arms (2)
Mindfulness Training
EXPERIMENTALBehavioral: Mindfulness-based Eating Awareness Training in IBS - The MB-IBS-EAT is an 8-week intervention with weekly 1-hour sessions in a web-based group format.
fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet
ACTIVE COMPARATORDietary: Low FODMAP Diet - Subjects in the FODMAP group will be provided dietary instructions by a registered dietician during weekly 1-hour sessions in a web-based group format.
Interventions
The MB-IBS-EAT is an 8-week intervention with weekly 1-hour sessions in a web-based group format.
Subjects in the FODMAP group will be provided dietary instructions by a registered dietician during weekly 1-hour sessions in a web-based group format
Eligibility Criteria
You may qualify if:
- Aged 18 and over
- Meets Rome IV criteria for diagnosis of Irritable Bowel Syndrome (IBS)
- Has legal and mental capacity to understand and sign an informed consent document
- Access to a computer or smart device with internet
You may not qualify if:
- Pregnancy
- Active malignancy in the previous five years
- Current or prior history of alcohol or drug abuse as defined by clinician
- Any history of eating disorder such as anorexia or bulimia
- Taking yoga or with prior history of mindfulness therapy within 3 months of enrollment
- Currently on a fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet
- Psychiatric illnesses other than depression or anxiety disorder
- Nausea or vomiting
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Baharak Moshiree, MD
Wake Forest University Health Sciences
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Masking Details
- The principal investigator will be blinded for the duration of the study. The study psychologist and the dietician will be blinded to the study results for the duration of the study.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 15, 2022
First Posted
November 30, 2022
Study Start
May 1, 2026
Primary Completion (Estimated)
July 1, 2026
Study Completion (Estimated)
July 1, 2026
Last Updated
April 23, 2026
Record last verified: 2025-08